Literature DB >> 16969433

Perinatal depression--assessment and management.

Anne Buist1.   

Abstract

BACKGROUND: Depression and anxiety often begin in pregnancy, particularly third trimester, therefore 'perinatal' rather than postnatal depression might be a better term to describe this disorder.
OBJECTIVE: This article outlines an approach to assessment and management of perinatal depression. DISCUSSION: Psychological difficulties are common after childbirth and have potentially serious consequences. Treatment needs to consider the complex interplay of biology and psychology, and both mother and infant need consideration. Early, assertive identification and sensitive management, mindful of risks and benefits to both mother and infant, is the best current approach to improving outcomes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16969433

Source DB:  PubMed          Journal:  Aust Fam Physician        ISSN: 0300-8495


  4 in total

1.  Auricular Treatment of Maternal Depressive Disorders.

Authors:  Nader Soliman
Journal:  Med Acupunct       Date:  2019-10-17

2.  Correlates of perinatal depression in HIV-infected women.

Authors:  Suad Kapetanovic; Shawna Christensen; Roksana Karim; Florence Lin; Wendy J Mack; Eva Operskalski; Toni Frederick; LaShonda Spencer; Alice Stek; Francoise Kramer; Andrea Kovacs
Journal:  AIDS Patient Care STDS       Date:  2009-02       Impact factor: 5.078

3.  Homeopathic Treatment for Postpartum Depression: A Case Report.

Authors:  Vitalie Văcăraş; George Vithoulkas; Anca Dana Buzoianu; Ioan Mărginean; Zoltan Major; Veronica Văcăraş; Romulus Dan Nicoară; Menachem Oberbaum
Journal:  J Evid Based Complementary Altern Med       Date:  2016-12-22

4.  Prevalence and risk factors of postpartum depression within one year after birth in urban slums of Dhaka, Bangladesh.

Authors:  Rashidul Azad; Rukhshan Fahmi; Sadichhya Shrestha; Hemraj Joshi; Mehedi Hasan; Abdullah Nurus Salam Khan; Mohiuddin Ahsanul Kabir Chowdhury; Shams El Arifeen; Sk Masum Billah
Journal:  PLoS One       Date:  2019-05-02       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.